Feed KRYS
KR
Krystal Biotech
KRYS · NASDAQ
$327.05 -1.88% (-$6.25)
1M -10.01%
Market Cap $9.6B
P/E Ratio 47.07x
Div. Yield -
ROE 17.53%
Bulios Fair Price
$205.49
37.2% downside
Preț actual
$327.05
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile KRYS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
11 /100
Expensive P/E 47.07x
EV/EBITDA 54.54x
P/S 24.78x
Growth
100 /100
Growing Book val. growth 32.67%
EPS growth N/A
Rev. growth N/A
Profitability
100 /100
Strong Gross margin 92.61%
Net margin 52.64%
Op. margin 41.45%
Quality
73 /100
Excellent ROIC 14.15%
ROE 17.53%
ROA 15.36%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 9.95x
Net debt/EBITDA -2.90x
Stability
38 /100
Moderate Beta 0.50x
EPS volatility 318.68%
Profitable years 3
Întreabă StockBot despre KRYS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Krish S. Krishnan
Employees
295
Headquarters
Pittsburgh
Evenimente viitoare
02 NOV.
Earnings
Upcoming earnings report